Triple therapy with low‐dose dapagliflozin plus saxagliptin versus dual therapy with each monocomponent, all added to metformin, in uncontrolled type 2 diabetes

AIM: To evaluate the efficacy and safety of triple therapy with low‐dose dapagliflozin plus saxagliptin added to metformin in uncontrolled type 2 diabetes. MATERIALS AND METHODS: This 24‐week, double‐blind trial (NCT02681094) randomized 883 patients (glycated haemoglobin [HbA1c] 7.5‐10.0%) on metfor...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Diabetes Obes Metab
Autors principals: Rosenstock, Julio, Perl, Shira, Johnsson, Eva, García‐Sánchez, Ricardo, Jacob, Stephan
Format: Artigo
Idioma:Inglês
Publicat: Blackwell Publishing Ltd 2019
Matèries:
Original Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6771748/
https://ncbi.nlm.nih.gov/pubmed/31144431
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.13795
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars